Regenerex Pharma Amends Bylaws, Changes Fiscal Year
Ticker: RGPX · Form: 8-K · Filed: Nov 12, 2025 · CIK: 1357878
| Field | Detail |
|---|---|
| Company | Regenerex Pharma, Inc. (RGPX) |
| Form Type | 8-K |
| Filed Date | Nov 12, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: bylaws, fiscal-year, corporate-governance
Related Tickers: RGXP
TL;DR
Regenerex Pharma (RGXP) just changed its bylaws and fiscal year end. Big deal for reporting.
AI Summary
Regenerex Pharma, Inc. filed an 8-K on November 12, 2025, reporting amendments to its Articles of Incorporation or Bylaws, and a change in its fiscal year. The company, formerly known as Peptide Technologies, Inc. and Eternelle Skincare Products Inc., is incorporated in Nevada and its fiscal year previously ended on March 31.
Why It Matters
Changes to a company's bylaws and fiscal year can impact reporting schedules and internal governance, potentially affecting investor analysis and operational planning.
Risk Assessment
Risk Level: low — This filing is procedural and does not involve financial distress or significant operational changes.
Key Players & Entities
- REGENEREX PHARMA, INC (company) — Registrant
- Peptide Technologies, Inc. (company) — Former company name
- Eternelle Skincare Products Inc. (company) — Former company name
- November 11, 2025 (date) — Date of earliest event reported
- November 12, 2025 (date) — Filing date
- 0331 (date) — Previous fiscal year end
FAQ
What specific amendments were made to the Articles of Incorporation or Bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the provided text.
What is the new fiscal year end date for Regenerex Pharma, Inc.?
The filing states there was a change in fiscal year, but the new end date is not specified in the provided text.
When was Regenerex Pharma, Inc. previously known as Peptide Technologies, Inc.?
The filing indicates a name change from Peptide Technologies, Inc. to Regenerex Pharma, Inc. on March 9, 2018.
In which state is Regenerex Pharma, Inc. incorporated?
Regenerex Pharma, Inc. is incorporated in Nevada.
What is the business address of Regenerex Pharma, Inc.?
The business address is 5348 Vegas Drive, Suite 177, Las Vegas, NV 89108.
Filing Stats: 442 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2025-11-12 15:10:14
Filing Documents
- ixform8k.htm (8-K) — 19KB
- 0001472375-25-000130.txt ( ) — 174KB
- rgpx-20251111.xsd (EX-101.SCH) — 3KB
- rgpx-20251111_lab.xml (EX-101.LAB) — 33KB
- rgpx-20251111_pre.xml (EX-101.PRE) — 22KB
- ixform8k_htm.xml (XML) — 3KB
03. Amendments to Articles of
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 22, 2025, the Board of Directors (the "Board") of Regenerex Pharma, Inc. (the "Company") approved a change to the Company's fiscal year end from March 31 to December 31 in accordance with Section 6 of the bylaws of the Company that authorize the Board to change the Company's fiscal year. The Company will file a transition report on Form 10-K for the transition period from April 1, 2025 to December 31, 2025. Contact: Regenerex Pharma, Inc. Company Ph: 877-761-RGPX (7479) Investor Relations Ph: (305) 927-5191 Email: investors@regenerexpharmainc.com regenerexpharmainc.com
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized. REGENEREX PHARMA, INC. By: /s/ Greg Pilant Date: November 12, 2025 Name: Greg Pilant Title: Chief Executive Officer